<DOC>
	<DOC>NCT00769275</DOC>
	<brief_summary>Asymptomatic subjects with Type 2 Diabetes Mellitus were randomized to either screening with Tc-99m sestamibi adenosine SPECT imaging or no screening. All patients will be followed for 5 years for the occurrence of cardiac death or non-fatal myocardial infarction. The aims are: 1. To prospectively assess the prevalence of silent myocardial ischemia in asymptomatic subjects with Type 2 Diabetes Mellitus. 2. To identify on the basis of clinical and/or biochemical variables in a high-risk cohort in which screening for coronary artery disease is appropriate. 3. To assess progression of (silent) myocardial ischemia after 3 years. 4. To assess the occurence of cardiac death or nonfatal myocardial infarction during 5 years follow-up in screened and not screened subjects.</brief_summary>
	<brief_title>Detection of Ischemia in Asymptomatic Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Age 5075 years Type 2 diabetes mellitus Angina or anginal equivalent Abnormal rest ECG (Q or ST depression) Known CAD Stress testing within the last 3 years</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>silent ischemia</keyword>
	<keyword>type 2 diabetes mellitus</keyword>
	<keyword>screening</keyword>
	<keyword>cardiac outcome</keyword>
	<keyword>Prevalence silent myocardial ischemia</keyword>
	<keyword>Cardiac outcome in screened and not-screened subjects</keyword>
</DOC>